Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. (Q37467387)

20 August 2017

1 reference

title

Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. (English)

1 reference

20 August 2017

0 references

3

Thomy de Ravel

1 reference

20 August 2017

Hilde Brems

1

1 reference

20 August 2017

Eline Beert

series ordinal

2

1 reference

20 August 2017

Eric Legius

series ordinal

4

1 reference

20 August 2017

publication date

1 May 2009

1 reference

Lancet Oncology Commission

20 August 2017

published in

1 reference

20 August 2017

volume

10

1 reference

20 August 2017

issue

5

1 reference

20 August 2017

page(s)

508-515

1 reference

A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

NF1 gene and neurofibromatosis 1

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Diagnosis of gastrointestinal stromal tumors: a consensus approach

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Von Recklinghausen neurofibromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

A genetic study of von Recklinghausen neurofibromatosis in south east Wales. II. Guidelines for genetic counselling

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Neurofibromatosis in children with Rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma study IV.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Associations of clinical features in neurofibromatosis 1 (NF1).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Outcomes of systematic screening for optic pathway tumors in children with Neurofibromatosis Type 1

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Malignant peripheral nerve sheath tumours in neurofibromatosis 1

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Loss of NF1 alleles in phaeochromocytomas from patients with type I neurofibromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Loss of neurofibromin in adrenal gland tumors from patients with neurofibromatosis type I

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Preliminary observations on genetic alterations in pilocytic astrocytomas associated with neurofibromatosis 1

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Molecular and cytogenetic analysis of tumors in von Recklinghausen neurofibromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

TP53 mutations are frequent in malignant NF1 tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Homozygous deletion of the neurofibromatosis-1 gene in the tumor of a patient with neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Homozygous inactivation of NF1 gene in a patient with familial NF1 and disseminated neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Signal therapy of NF1-deficient tumor xenograft in mice by the anti-PAK1 drug FK228.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

[Type I neurofibromatosis, pheochromocytoma and somatostatinoma of the ampulla. Literature review]

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Ampullary somatostatinomas and jejunal gastrointestinal stromal tumor in a patient with Von Recklinghausen's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

1 reference

7 January 2021

The Third Intergroup Rhabdomyosarcoma Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Neurofibromatosis 1: clinical manifestations and diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Sarcomas in children with neurofibromatosis type 1-poor prognosis despite aggressive combined therapy in four patients treated in a single oncological institution

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Mortality in neurofibromatosis 1: an analysis using U.S. death certificates.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

An estimate of the heritable fraction of childhood cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Elevated risk for MPNST in NF1 microdeletion patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

[18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

1 reference

7 January 2021

Synchronous neuroblastoma and von Recklinghausen's disease: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Germline PTPN11 missense mutation in a case of Noonan syndrome associated with mediastinal and retroperitoneal neuroblastic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Tumor predisposition in Costello syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Somatic mutation analysis in NF1 café au lait spots reveals two NF1 hits in the melanocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Germline and somatic NF1 gene mutations in plexiform neurofibromas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Germline and somaticNF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Mouse models of tumor development in neurofibromatosis type 1

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Mouse tumor model for neurofibromatosis type 1

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

An integrated genomic analysis of human glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

The NF1 tumor suppressor critically regulates TSC2 and mTOR.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970033-6

7 January 2021

10.1016/S1470-2045(09)70033-6

Identifiers

DOI

1 reference

20 August 2017

1 reference